Differential diagnosis and treatment of diabetes mellitus associated with Cushig’s disease
https://doi.org/10.14341/omet2017253-58
Abstract
Diabetes mellitus associated with endogenic hypercortisolism is one of the most frequent symptoms of Cushing’s disease and may mask other implications. Achievement of the disease’s remission not always leads to complete involution of its complications. The new glucose-lowering drugs can exert a complex positive impact in patients with hypercortisolemic comorbidities. To treat diabetes mellitus associated with the central hypercortisolism groups of dipeptidyl peptidase 4 inhibitors and sodium-glucose co-transporter-2 inhibitors should be taken into account.
About the Authors
Larisa K. DzeranovaEndocrinology Research Centre
Russian Federation
ScD
Ekaterina E. Bibik
Endocrinology Research Centre
Russian Federation
resident
Ekaterina A. Pigarova
Endocrinology Research Centre
Russian Federation
PhD
Taras S. Panevin
Endocrinology Research Centre
Russian Federation
resident
Andrey Yu. Grigor'ev
Endocrinology Research Centre
Russian Federation
ScD
References
1. Мельниченко Г.А., Дедов И.И., Белая Ж.Е., и др. Болезнь Иценко-Кушинга: клиника, диагностика, дифференциальная диагностика, методы лечения. Федеральные клинические рекомендации //Проблемы эндокринологии. – 2015. – Т. 61. – № 2. – С. 55-77. [Melnichenko GA, Dedov II, Belaya ZE, et al. Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2015;61(2):55-77.] doi: 10.14341/probl201561255-77.
2. Александров А.А., Марова Е.И., Бельченко Л.В., Жимирикина М.Л. Гиперкортицизм: заболеваемость, смертность и факторы риска развития сердечно-сосудистых заболеваний // Врач. — 2007. — № 5. – с.14-16. [Aleksandrov AA, Marova EI, Bel'chenko LV, Zhimirikina ML. Giperkortitsizm: zabolevaemost', smertnost' i faktory riska razvitiya serdechno-sosudistykh zabolevaniy. Vrach. 2007;(5):14-16.]
3. Arnaldi G, Mancini T, Polenta B, Boscaro M. Cardiovascular Risk In Cushing's Syndrome. Pituitary. 2005;7(4):253-256. doi: 10.1007/s11102-005-1172-7.
4. Sharma ST, Nieman LK, Feelders RA. Comorbidities in Cushing’s disease. Pituitary. 2015;18(2):188-194. doi: 10.1007/s11102-015-0645-6.
5. Lonser RR, Nieman L, Oldfield EH. Cushing's disease: pathobiology, diagnosis, and management. Journal of Neurosurgery. 2017;126(2):404-417. doi: 10.3171/2016.1.jns152119.
6. Giordano C, Guarnotta V, Pivonello R, et al. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? European Journal of Endocrinology. 2013;170(2):311-319. doi: 10.1530/eje-13-0754.
7. Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature. The Journal of Clinical Endocrinology & Metabolism. 2011;96(3):632-642. doi: 10.1210/jc.2010-1942.
8. Steffensen C, Pereira AM, Dekkers OM, Jørgensen JOL. DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis. European Journal of Endocrinology. 2016;175(6):R247-R253. doi: 10.1530/eje-16-0434.
9. Bae EJ. DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control. Archives of Pharmacal Research. 2016;39(8):1114-1128. doi: 10.1007/s12272-016-0813-x.
10. Remm F, Franz W-M, Brenner C. Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease. European Heart Journal – Cardiovascular Pharmacotherapy. 2016;2(3):185-193. doi: 10.1093/ehjcvp/pvv044.
11. Chrysant SG. Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs. Drugs of Today. 2017;53(3):191. doi: 10.1358/dot.2017.53.3.2555985.
Supplementary files
|
|
1. Рис. 1. Внешний вид пациентки до оперативного лечения. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(482KB)
|
Indexing metadata ▾ | |
|
|
2. Рис. 2. Данные МР-исследования головного мозга до оперативного лечения. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(671KB)
|
Indexing metadata ▾ | |
|
|
3. Рис. 3. Внешний вид пациентки через 6 месяцев после оперативного лечения. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(80KB)
|
Indexing metadata ▾ | |
|
|
4. Рис. 4. Данные МР-исследования головного мозга через 6 месяцев после оперативного лечения. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(705KB)
|
Indexing metadata ▾ | |
Review
For citations:
Dzeranova L.K., Bibik E.E., Pigarova E.A., Panevin T.S., Grigor'ev A.Yu. Differential diagnosis and treatment of diabetes mellitus associated with Cushig’s disease. Obesity and metabolism. 2017;14(2):53-58. (In Russ.) https://doi.org/10.14341/omet2017253-58
Views:
6990
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
